tiprankstipranks
Trending News
More News >

Patricia Allen Insider Profile

11 Followers
Patricia Allen, CFO at Larimar Therapeutics, holds 0.00 shares in Larimar Therapeutics (Ticker: LRMR), holds 0.00 shares in Deciphera Pharmaceuticals (Ticker: DCPH), holds ― shares in Kineta (Ticker: KANT). Most recently, Patricia Allen ― shares of Larimar Therapeutics on ― for an estimated value of ―.
tipranks
Patricia Allen

Patricia Allen
Larimar Therapeutics (LRMR)
CFO

Ranked #71,856 out of 106,487 Corporate Insiders

Profitable Transactions

0%
0 out of 2 Profitable Transactions

Average Return

-20.30%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$840K
55.54%
44.46%
0.00%
A breakdown of Patricia Allen's holdings

Insider Roles

Zenas BioPharma, Inc.
(ZBIO)
Director
Alnylam Pharma
(ALNY)
VP of Finance and Treasurer
Larimar Therapeutics
(LRMR)
CFO
Roles that Patricia Allen holds in companies

Most Profitable Insider Trade

Stock:
Zenas BioPharma, Inc.
(ZBIO)
Rating:Informative Buy
Date:Feb 13, 2026 - Today
Return:-8.90%
The most profitable trade made by Patricia Allen

Patricia Allen's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Larimar Therapeutics
CFO
$0.00
DCPH
Deciphera Pharmaceuticals
Jan 28, 2020
Informative Buy
98.75K
$0.00
KANT
Kineta
Zenas BioPharma, Inc.
Feb 13, 2026
Director
Informative Buy
499.75K
$466.31K
Alnylam Pharma
Apr 24, 2009
VP of Finance and Treasurer
Uninformative Sell
440.50K
$373.29K
List of latest transactions for each holding click on a transaction to see Patricia Allen's performance on stock

Patricia Allen insider profile FAQ

What is the percentage of profitable transactions made by Patricia Allen?
The percentage of profitable transactions made by Patricia Allen is 0%.
    What is the average return per transaction made by Patricia Allen?
    The average return per transaction made by Patricia Allen is -20.30%.
      What stocks does Patricia Allen hold?
      Patricia Allen holds: LRMR, DCPH, KANT, ZBIO, ALNY stocks.
        What was Patricia Allen’s latest transaction?
        Patricia Allen latest transaction was an Uninformative Buy of ―.
          What was Patricia Allen's most profitable transaction?
          Patricia Allen’s most profitable transaction was an Informative Buy of ZBIO stock on February 13, 2026. The return on the trade was -8.90%.
            What is Patricia Allen's role in Larimar Therapeutics?
            Patricia Allen's role in Larimar Therapeutics is CFO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.